This weekly research roundup covers the open-label ERASE LC remdesivir trial published in Oxford Open Immunology, a multicenter US survey in the American Journal of Industrial Medicine finding persistent Long COVID in about 11% of healthcare personnel, and PolyBio Research Foundation's $15 million funding announcement for its Long COVID Cure Initiative at a Boston event with Massachusetts Governor Maura Healey and funders Steve and Judy Pagliuca. The piece also notes PolyBio's plans to extend its clinical research infrastructure to chronic Lyme disease.
Research Desk
Research updates, September 29
September 29, 2026
The Sick Times rounds up the ERASE LC remdesivir feasibility trial, new US healthcare-worker prevalence data, and a $15 million boost for PolyBio's Long COVID Cure Initiative.
Save For Later
Email yourself a link to this article.
Saved. Check your email app.
Something didn't go through — try again.